The coprimary endpoints include a comparison of the proportion of patients achieving low disease activity in the T2T and UC groups and assessment of the feasibility of implementing T2T in rheumatology practices , specifically assessment of the rates of treatment acceleration , frequency of visits , time to next visit conditional on disease activity , and probability of acceleration conditional on disease activity in the 2 groups .